Association between PIK3CA activating mutations and outcomes in early-stage invasive lobular breast carcinoma treated with adjuvant systemic therapy
By:
Authors
Domen Ribnikar
Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Faculty of Medicine Ljubljana, University of Ljubljana, Ljubljana, Slovenia
Valentina Jeric Horvat
Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Ivica Ratosa
Faculty of Medicine Ljubljana, University of Ljubljana, Ljubljana, Slovenia
Department of Radiation Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Zachary W Veitch
Division of Medical Oncology and Hematology, Royal Victoria Hospital, Bariie, USA
Biljana Grcar Kuzmanov
Department of Pathology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Srdjan Novakovic
Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Erik Langerholc
Institute of Biostatistics and informatics, Faculty of Medicine Ljubljana, University of Ljubljana, Ljubljana, Slovenia
Eitan Amir
Division of Medical Oncology and Hematology, University of Toronto and Princess Margaret Cancer Centre, Toronto, Canada
Bostjan Seruga
Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Faculty of Medicine Ljubljana, University of Ljubljana, Ljubljana, Slovenia
Language: English
Page range: 220 - 228
Submitted on: Feb 13, 2023
Accepted on: May 18, 2023
Published on: Jun 21, 2023
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2023 Domen Ribnikar, Valentina Jeric Horvat, Ivica Ratosa, Zachary W Veitch, Biljana Grcar Kuzmanov, Srdjan Novakovic, Erik Langerholc, Eitan Amir, Bostjan Seruga, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.